The Role of Monoclonal Antibodies in the Treatment of Atherosclerosis

Jimmy Hong, Leonardo Salazar, Joanne Acevedo, Ravi Thakker, Hani Jneid, Mostafa Shalaby, Jennifer McCracken, Wissam Khalife

Research output: Contribution to journalReview articlepeer-review


Atherosclerosis is an inflammatory disease that involves antibody immune responses. Progression of hyperlipidemia can lead to atherosclerosis and subsequently cardiovascular diseases with high mortality. Additional lipid-lowering therapies other than statins are currently being studied, such as monoclonal antibodies. In this contemporary review, we examine the various monoclonal antibody therapies targeted toward atherosclerotic disease.

Original languageEnglish (US)
Article number101585
JournalCurrent Problems in Cardiology
Issue number4
StatePublished - Apr 2023

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'The Role of Monoclonal Antibodies in the Treatment of Atherosclerosis'. Together they form a unique fingerprint.

Cite this